Six Months of Treatment with Risperidone May Be Associated with Nonsignificant Abnormalities of Liver Function Tests in Children and Adolescents: A Longitudinal, Observational Study from Turkey

Erdogan A., Karaman M. G., Ozdemir E., Yurteri N., Tufan A. E., Kurcer M. A.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, vol.20, no.5, pp.407-413, 2010 (SCI-Expanded) identifier identifier identifier


Objective: Risperidone is a promising agent for the treatment of schizophrenia, Tourette's disorder, mood disorders, and disruptive behavior disorders in young populations. However, adverse effects of risperidone may take a long time to emerge. The objective of this study was to investigate the changes in the liver function tests (LFTs) associated with more than 6 months of risperidone treatment in children and adolescents.